CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis

M. C. Finazzi, A. Carobbio, F. Cervantes, I. M. Isola, A. M. Vannucchi, P. Guglielmelli, A. Rambaldi, G. Finazzi, G. Barosi, T. Barbui

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1209-1210
Number of pages2
Issue number5
Publication statusPublished - May 11 2015

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this